BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 35499593)

  • 1. E3 Ligase FBXW2 Is a New Therapeutic Target in Obesity and Atherosclerosis.
    Wang C; Xu W; Chao Y; Liang M; Zhang F; Huang K
    Adv Sci (Weinh); 2020 Oct; 7(20):2001800. PubMed ID: 33101872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of a panel of circulating microRNAs in screening prostate cancer.
    Sun C; Lu C; Li X; Li R; Wen Z; Ge Z; Chen W; Li Y; Sun S; Yang Q; Tao L; Li H; Lai Y
    Transl Cancer Res; 2024 Feb; 13(2):686-698. PubMed ID: 38482417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitination in Cancer Metastasis: Emerging Functions, Underlying Mechanisms, and Clinical Implications.
    Barik GK; Sahay O; Islam S; Ghate NB; Kalita B; Alam A
    Technol Cancer Res Treat; 2023; 22():15330338231210720. PubMed ID: 37899723
    [No Abstract]   [Full Text] [Related]  

  • 4. FBXW2 suppresses breast tumorigenesis by targeting AKT-Moesin-SKP2 axis.
    Barik GK; Sahay O; Mukhopadhyay A; Manne RK; Islam S; Roy A; Nath S; Santra MK
    Cell Death Dis; 2023 Sep; 14(9):623. PubMed ID: 37736741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Tumor-to-tumor metastasis with prostate cancer metastatic to lung cancer: the first reported case.
    Liu S; Li H; Dong Y; Zhang D
    Front Oncol; 2023; 13():1238331. PubMed ID: 37664049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPN12 down-regulated by miR-146b-3p gene affects the malignant progression of laryngeal squamous cell carcinoma.
    Lan L; Cao H; Zhao L; Cui W; Wang B
    Open Med (Wars); 2023; 18(1):20230727. PubMed ID: 37333450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elastic Fibers and F-Box and WD-40 Domain-Containing Protein 2 in Bovine Periosteum and Blood Vessels.
    Akiyama M
    Biomimetics (Basel); 2022 Dec; 8(1):. PubMed ID: 36648793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-cancer analysis of FBXW family with potential implications in prognosis and immune infiltration.
    Huang T; OuYang X; Li J; Shi B; Shan Z; Shi Z; Yang Z
    Front Immunol; 2022; 13():1084339. PubMed ID: 36591289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.
    Yin Y; Xie CM; Li H; Tan M; Chen G; Schiff R; Xiong X; Sun Y
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20528-20538. PubMed ID: 31548378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-box only protein 9 and its role in cancer.
    Hussain S; Dong J; Ma X; Li J; Chen S; Clement A; Liu H
    Mol Biol Rep; 2022 Feb; 49(2):1537-1544. PubMed ID: 35025031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins.
    Zheng N; Wang Z; Wei W
    Int J Biochem Cell Biol; 2016 Apr; 73():99-110. PubMed ID: 26860958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBXW2 inhibits prostate cancer proliferation and metastasis via promoting EGFR ubiquitylation and degradation.
    Zhou T; Chen T; Lai B; Zhang W; Luo X; Xia D; Fu W; Xu J
    Cell Mol Life Sci; 2022 May; 79(5):268. PubMed ID: 35499593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXW2 suppresses migration and invasion of lung cancer cells via promoting β-catenin ubiquitylation and degradation.
    Yang F; Xu J; Li H; Tan M; Xiong X; Sun Y
    Nat Commun; 2019 Mar; 10(1):1382. PubMed ID: 30918250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor.
    Xu J; Zhou W; Yang F; Chen G; Li H; Zhao Y; Liu P; Li H; Tan M; Xiong X; Sun Y
    Nat Commun; 2017 Jan; 8():14002. PubMed ID: 28090088
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.